Skip to main content

Table 5 Interpregnancy intervals by statistically significant study variables

From: Induced abortion - impact on a subsequent pregnancy in first-time mothers: a registry-based study

 

Yes

 

No

   

n

%

N

%

p

 
 

Late first visit to MHC

   

<6 months

10

9.52

95

90.48

<0.0001

 

6−12 months

30

16.85

148

83.15

  

>12 months

305

6.65

4,283

93.35

  
 

Participation to first trim serum screening

     

<6 months

13

12.38

92

87.62

<0.0001

 

6−12 months

41

23.03

137

76.97

  

>12 months

1605

34.98

2,983

65.02

  
 

Placenta sample taken

     

<6 months

2

1.90

103

98.10

0.0003

 

6−12 months

7

3.93

171

96.07

  

>12 months

41

0.89

4,547

99.11

  
 

Blood glucose tolerance test performed

  

<6 months

24

22.86

81

77.14

<0.0001

 

6−12 months

51

28.65

127

71.35

  

>12 months

2,144

46.73

2,444

53.27

  
 

Diagnoses O14.0

    

<6 months

5

4.76

100

95.24

0.0073

 

6−12 months

5

2.81

173

97.19

  

>12 months

64

1.39

4,524

98.61

  
 

Diagnoses 014.0/1/9

     

<6 months

7

6.67

98

93.33

0.0067

 

6−12 months

8

4.49

170

95.51

  

>12 months

111

2.42

4,477

97.58

  
 

Diagnoses O36.5

     

<6 months

2

1.90

103

98.10

0.0153

 

6−12 months

7

3.93

171

96.07

  

>12 months

61

1.33

4,527

98.67

  
 

Number of check-ups at hospital

  

Number of all follow-up visits

  
 

Mean (SD)

95 % CI

P

Mean (SD)

95 % CI

p

<6 months

3.7 (0.3)

3.2−4.3

0.0376

17.9 (0.1)

16.9−18.8

0.0294

6−12 months

3.5 (0.2)

3.1−3.9

 

16.8 (0.4)

16.1−17.5

 

>12 months

3.1 (0.0)

3.0−3.2

 

16.6 (0.1)

16.5−16.8

 
  1. Diagnoses O14.0: Mild to moderate pre-eclampsia
  2. O14.0/1/9: Mild to moderate pre-eclampsia/Severe pre-eclampsia/Unspecified pre-eclampsia
  3. O36.5: Maternal growth for known or suspected poor fetal growth